ESC 365 - Associate Professor David R Van Wagoner

Speaker illustration

Associate Professor David R Van Wagoner

Cleveland Clinic, Cleveland (United States of America)

Member of:

European Society of Cardiology

European Heart Rythm Association

Dysregulated Ca<sup>2+</sup> cycling in atrial fibrillation

Date: 4 April 2023

Journal: European Heart Journal

Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?

Date: 1 March 2013

Journal: Cardiovascular Research

Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model

Date: 30 November 2010

Journal: Cardiovascular Research

Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality

Date: 18 November 2010

Journal: European Heart Journal

Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?

Date: 30 June 2008

Journal: EP Europace Journal

Evaluating the impact of atrial dilatation on atrial calcium cycling

Date: 7 April 2008

Journal: European Heart Journal

ESC 365 is supported by

novartis

Explore sponsored resources